Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8 Gynecologic 4 Genitourinary 3 Plasma cell 2 Other hematologic neoplasm 2 Breast 2 Thoracic 1 NET 1 Lymphoid 1 Head & Neck 1 Endocrine 1

Conditions

Neuroendocrine Tumors 111 Pheochromocytoma 33 Carcinoma, Neuroendocrine 33 Pituitary Neoplasms 28 Thyroid Cancer, Papillary 26 Paraganglioma 26 Adrenocortical Carcinoma 21 Neoplasms 19 Gastro-enteropancreatic neuroendocrine tumor 19 Thyroid Neoplasms 17 Adrenal Gland Neoplasms 16 Multiple Endocrine Neoplasia Type 1 14 Stomach Neoplasms 13 Prostatic Neoplasms 13 Pancreatic Neoplasms 13 Carcinoid Tumor 13 Sarcoma 12 Lung Neoplasms 12 Breast Neoplasms 12 Thyroid Carcinoma, Anaplastic 11 Adenoma, Islet Cell 11 Small Cell Lung Carcinoma 10 Ovarian Neoplasms 10 Neuroblastoma 10 Neoplasm Metastasis 10 Colorectal Neoplasms 10 Carcinoma, Hepatocellular 10 Brain Neoplasms 10 Meningioma 9 Esophageal Neoplasms 9

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Frailty × Endocrine × Clear all

NCT05554003 2024-11-18

MeTe

European Institute of Oncology

Phase 2 Recruiting

Frailty, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡